Immunic
IMUX
IMUX
65 hedge funds and large institutions have $95M invested in Immunic in 2018 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 20 increasing their positions, 9 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.12% more ownership
Funds ownership: 0.71% → 0.82% (+0.12%)
77% less call options, than puts
Call options by funds: $754K | Put options by funds: $3.29M
Holders
65
Holding in Top 10
1
Calls
$754K
Puts
$3.29M
Top Buyers
| 1 | +$8.82M | |
| 2 | +$7.5M | |
| 3 | +$2.29M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.75M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.09M |
Top Sellers
| 1 | -$7.95M | |
| 2 | -$2.77M | |
| 3 | -$1.32M | |
| 4 |
Goldman Sachs
New York
|
-$1.11M |
| 5 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
-$416K |